On the mechanism of protection of distal joints after local gene transfer in collagen-induced arthritis.
Considerable interest has been generated by the observation that adenovirus-mediated gene delivery to a single arthritic joint results in suppression of arthritis in distal joints associated with the presence of small numbers of transduced cells in distal joints. It has been proposed that this is mediated by trafficking of transduced cells from the injected to distal joints. There are, however, alternative explanations that have not been explored, including the possibility that transgene protein or infectious virions circulate to distal sites. To investigate these possibilities, a replication-incompetent adenovirus encoding viral IL-10 (vIL-10) was administered to naive mice and to mice with collagen-induced arthritis by intraarticular, periarticular, or intravenous injection. In all cases, the ability to protect distal joints correlated with serum levels of vIL-10 protein. After intraarticular or intravenous injection, vIL-10 cDNA could be detected not only in distal joints, but also in the liver, which is the major target of circulating adenovirus, demonstrating that adenovirus circulating through the bloodstream is taken up by the joint tissue. Periarticular administration of adenovirus, which resulted in lower serum levels of vIL-10, protected only the injected paws and failed to induce trafficking immunoregulatory cells capable of suppressing distal disease. These observations suggest that circulating vIL-10 protein is the major mediator of distal protection. The presence of small numbers of transduced cells at distal sites can be accounted for by transduction of distal synovium after entry of adenovirus virions into the circulation.
Watanabe
S
S
William S. Rowe Division of Rheumatology, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Kim
K N
KN
Imagawa
T
T
Thornton
S
S
Grom
A
A
Hirsch
R
R
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000517:prevention & control*; D003094:Collagen / Q000633:toxicity; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000008:administration & dosage*; D007270:Injections, Intra-Articular; D007275:Injections, Intravenous; D016753:Interleukin-10 / Q000097:blood / Q000235:genetics / Q000494:pharmacology*; D007596:Joints; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA
D016753:Interleukin-10; D003094:Collagen